MGTX — MeiraGTx Holdings Share Price
0.000.00%
Last trade - 00:00- $426.61m
- $396.17m
- $33.28m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.29 | ||
| Price to Tang. Book | 6.37 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 12.82 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -78.58% | ||
| Return on Equity | -143.48% | ||
| Operating Margin | -493.44% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 15.56 | 37.7 | 15.92 | 14.02 | 33.28 | 185.44 | 221.16 | 20.15% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.
Directors
- Keith Harris NEC (68)
- Alexandria Forbes PRE (56)
- Richard Giroux CFO (48)
- Robert Wollin GCN (45)
- Stuart Naylor OTH (58)
- Robert Zeldin OTH (58)
- Ellen Hukkelhoven IND (34)
- Martin Indyk IND (69)
- Arnold Levine IND (81)
- Joel Marcus IND (73)
- Neil Mendoza IND (61)
- Nicole Seligman IND (63)
- Thomas Shenk IND (73)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 1st, 2018
- Public Since
- June 8th, 2018
- No. of Shareholders
- 51
- No. of Employees
- 381
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 78,854,936
- Address
- 450 EAST 29TH STREET, 14TH FLOOR, NEW YORK, 10016
- Web
- https://meiragtx.com/
- Phone
- +1 6468607985
- Auditors
- Ernst & Young LLP
Upcoming Events for MGTX
MeiraGTx Holdings PLC Annual Shareholders Meeting
Q2 2025 MeiraGTx Holdings PLC Earnings Release
Similar to MGTX
2Seventy Bio
NASDAQ Global Select Market
4D Molecular Therapeutics
NASDAQ Global Select Market
Aardvark Therapeutics
NASDAQ Global Select Market
AbCellera Biologics
NASDAQ Global Select Market
AbSci
NASDAQ Global Select Market
FAQ
What is the MeiraGTx Holdings share price?
As of Today at 21:59 UTC, shares in MeiraGTx Holdings are trading at $5.41. This share price information is delayed by 15 minutes.
How has the MeiraGTx Holdings share price performed this year?
Shares in MeiraGTx Holdings last closed at $5.41 and the price had moved by +3.05% over the past 365 days. In terms of relative price strength the MeiraGTx Holdings share price has underperformed the S&P500 Index by -3.11% over the past year.
What are the analyst and broker recommendations for MeiraGTx Holdings?
The overall consensus recommendation for MeiraGTx Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the MeiraGTx Holdings dividend yield?
MeiraGTx Holdings does not currently pay a dividend.
Does MeiraGTx Holdings pay a dividend?
MeiraGTx Holdings does not currently pay a dividend.
When does MeiraGTx Holdings next pay dividends?
MeiraGTx Holdings does not currently pay a dividend.
How do I buy MeiraGTx Holdings shares?
To buy shares in MeiraGTx Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of MeiraGTx Holdings?
As of the previous close price of $5.41, shares in MeiraGTx Holdings had a market capitalisation of $426.61m.
Where are MeiraGTx Holdings shares listed?
Here are the trading details for MeiraGTx Holdings:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: MGTX
What kind of share is MeiraGTx Holdings?
Based on an overall assessment of its quality, value and momentum MeiraGTx Holdings is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a MeiraGTx Holdings share price forecast for 2025?
The analyst consensus target price for shares in MeiraGTx Holdings is $23.60. That is 336.23% above the last closing price of $5.41.
Analysts covering MeiraGTx Holdings currently have a consensus Earnings Per Share (EPS) forecast of $0.02 for the next financial year.
Find out moreWhat is the trend in the MeiraGTx Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MeiraGTx Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -2.36%.
As of the last closing price of $5.41, shares in MeiraGTx Holdings were trading -3.67% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the MeiraGTx Holdings PE Ratio?
The MeiraGTx Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $5.41.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of MeiraGTx Holdings?
MeiraGTx Holdings' management team is headed by:
- Keith Harris - NEC
- Alexandria Forbes - PRE
- Richard Giroux - CFO
- Robert Wollin - GCN
- Stuart Naylor - OTH
- Robert Zeldin - OTH
- Ellen Hukkelhoven - IND
- Martin Indyk - IND
- Arnold Levine - IND
- Joel Marcus - IND
- Neil Mendoza - IND
- Nicole Seligman - IND
- Thomas Shenk - IND